A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)?
<b>Background/Objectives:</b> Approximately one in five individuals will experience major depressive disorder (MDD), and 30% exhibit resistance to standard antidepressant treatments, resulting in a diagnosis of treatment-resistant depression (TRD). Historically, opium was used effectivel...
Saved in:
| Main Authors: | Shaul Schreiber, Lee Keidan, Chaim G. Pick |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/2/208 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Models of neuroinflammation for the assessment of kappa-opioid receptor ligands
by: K. Yu. Kalitin, et al.
Published: (2023-05-01) -
Mirtazapine: An Antidepressant for Treating Chronic, Refractory Nausea and Vomiting in a Patient With Metastatic Sarcoma Receiving Palliative Care: A Case Report
by: Seyedeh Golnaz Ziaei, et al.
Published: (2024-11-01) -
Nose-to-Brain Delivery of Chitosan-Grafted Leciplexes for Promoting the Bioavailability and Antidepressant Efficacy of Mirtazapine: In Vitro Assessment and Animal Studies
by: Amani M. El Sisi, et al.
Published: (2025-01-01) -
Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
by: Barkha J. Yadav-Samudrala, et al.
Published: (2024-03-01) -
Erratum: Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice
by: Frontiers Production Office
Published: (2025-04-01)